{"id":51505,"date":"2024-05-26T10:07:37","date_gmt":"2024-05-26T08:07:37","guid":{"rendered":"https:\/\/www.fyb.de\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/"},"modified":"2024-05-28T18:07:37","modified_gmt":"2024-05-28T16:07:37","slug":"vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round","status":"publish","type":"post","link":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/","title":{"rendered":"Vogel Heerma Waitz advises Captain T Cell on seed financing round"},"content":{"rendered":"<p>Berlin \u2014 Captain T Cell GmbH, a biotech\u00adno\u00adlogy company deve\u00adlo\u00adping next-gene\u00adra\u00adtion T cells against solid tumors, has successfully closed a seed finan\u00adcing round of 8.5 million euros. A consor\u00adtium of expe\u00adri\u00aden\u00adced life science inves\u00adtors, inclu\u00adding i&amp;i Biotech Fund I SCSp, Bran\u00adden\u00adburg Kapi\u00adtal GmbH and HIL-INVENT Ges.m.b.H, parti\u00adci\u00adpa\u00adted in the&nbsp;round.<\/p>\n<p>In addi\u00adtion, the Fede\u00adral Minis\u00adtry of Educa\u00adtion and Rese\u00adarch (BMBF) supports the company through its renow\u00adned GO-Bio program. The finan\u00adcing also marks the appoint\u00adment of biotech vete\u00adran J\u00f6rn Aldag as Chair\u00adman of the Advi\u00adsory Board. \u2014 Dr. Lorenz Frey and Dr. Frank Vogel from the law firm Vogel Heerma Waitz advi\u00adsed Captain T&nbsp;Cell.<\/p>\n<p>The capi\u00adtal from the seed finan\u00adcing round will be used to bring a new gene\u00adra\u00adtion of T\u2011cell thera\u00adpies against solid tumors into the clinic.<\/p>\n<p>Captain T Cell is deve\u00adlo\u00adping TCR\u2011T cells with increased effi\u00adcacy for solid tumors that cannot be trea\u00adted with exis\u00adting thera\u00adpies. Using a series of novel tech\u00adno\u00adlo\u00adgies, Captain T Cell gene\u00adra\u00adtes TCR\u2011T cells with increased persis\u00adtence and the ability to effec\u00adtively coun\u00adter\u00adact the hostile tumor microen\u00advi\u00adron\u00adment of diffi\u00adcult-to-treat solid tumors. In precli\u00adni\u00adcal in vivo models, the company has succee\u00added in comple\u00adtely rejec\u00adting aggres\u00adsive tumors with these effi\u00adcacy-enhan\u00adced T cells. A key tech\u00adno\u00adlogy deve\u00adlo\u00adped by the Captain T Cell team is the company\u2019s proprie\u00adtary TCR-ALLO plat\u00adform for off-the-shelf treat\u00adment of solid tumors. The TCR-ALLO plat\u00adform is a univer\u00adsal tool that can be exten\u00added to a variety of cancer indications.<\/p>\n<p>The company is a spin-off of the renow\u00adned Max Delbr\u00fcck Center in Berlin, Germany, a leading Euro\u00adpean biome\u00addi\u00adcal rese\u00adarch insti\u00adtu\u00adtion. The Insti\u00adtute provi\u00added valuable finan\u00adcial and infra\u00adstruc\u00adtu\u00adral support during the pre-seed phase and, toge\u00adther with its tech\u00adno\u00adlogy trans\u00adfer part\u00adner Ascen\u00adion, remains a close part\u00adner for future ventures.<\/p>\n<p>Captain T Cell is based in Sch\u00f6nefeld\/Berlin and is supported by the expe\u00adri\u00aden\u00adced Euro\u00adpean inves\u00adtors i&amp;i Biotech Fund I SCSp, Bran\u00adden\u00adburg Kapi\u00adtal GmbH and HIL-INVENT Ges.m.b.H.. Captain T Cell was foun\u00added by an ambi\u00adtious team of immuno-onco\u00adlogy experts. The tech\u00adno\u00adlo\u00adgies were deve\u00adlo\u00adped at the Max Delbr\u00fcck Center for Mole\u00adcu\u00adlar Medi\u00adcine in the Helm\u00adholtz Asso\u00adcia\u00adtion in Berlin. www.captaintcell.com<\/p>\n<p><strong>Consul\u00adtant: Vogel Heerma Waitz<\/strong><\/p>\n<p>Dr. Lorenz Frey, Dr. Frank&nbsp;Vogel<\/p>\n<p><strong>About Vogel Heerma Waitz<\/strong><\/p>\n<p>Vogel Heerma Waitz is a Berlin-based law firm specia\u00adli\u00adzing in growth capi\u00adtal, tech\u00adno\u00adlogy and&nbsp;media.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Berlin \u2014 Captain T Cell GmbH, a biotech\u00adno\u00adlogy company deve\u00adlo\u00adping next-gene\u00adra\u00ad\u00adtion T cells against solid tumors, has successfully closed a seed finan\u00adcing round of 8.5 million euros. A consor\u00adtium of expe\u00adri\u00aden\u00adced life science inves\u00adtors, inclu\u00adding i&amp;i Biotech Fund I SCSp, Bran\u00adden\u00adburg Kapi\u00adtal GmbH and HIL-INVENT Ges.m.b.H, parti\u00adci\u00adpa\u00adted in the&nbsp;round. In addi\u00adtion, the Fede\u00adral Minis\u00adtry&nbsp;of&nbsp;[\u2026]<\/p>\n","protected":false},"author":2,"featured_media":51502,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"wp_typography_post_enhancements_disabled":false,"footnotes":""},"categories":[886,1364,1366,1367,1369,1373],"tags":[],"class_list":["post-51505","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-general-en","category-featured-en","category-news-en","category-lawyers-tax-advisors-auditors-en","category-investors","category-venture-capital-en"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v25.1 - https:\/\/yoast.com\/wordpress\/plugins\/seo\/ -->\n<title>Vogel Heerma Waitz advises Captain T Cell on seed financing round - FYB Financial Yearbook<\/title>\n<meta name=\"description\" content=\"Berlin, Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, successfully closes a seed financing round of 8.5 million euros.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Vogel Heerma Waitz advises Captain T Cell on seed financing round - FYB Financial Yearbook\" \/>\n<meta property=\"og:description\" content=\"Berlin, Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, successfully closes a seed financing round of 8.5 million euros.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/\" \/>\n<meta property=\"og:site_name\" content=\"FYB Financial Yearbook\" \/>\n<meta property=\"article:published_time\" content=\"2024-05-26T08:07:37+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2024-05-28T16:07:37+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/05\/olav-wilms1024x1024-768113175.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"1024\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Tatjana Anderer\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Tatjana Anderer\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/\"},\"author\":{\"name\":\"Tatjana Anderer\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\"},\"headline\":\"Vogel Heerma Waitz advises Captain T Cell on seed financing round\",\"datePublished\":\"2024-05-26T08:07:37+00:00\",\"dateModified\":\"2024-05-28T16:07:37+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/\"},\"wordCount\":396,\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/05\/olav-wilms1024x1024-768113175.jpg\",\"articleSection\":[\"General\",\"Featured\",\"News\",\"Lawyers\/Tax-advisors\/Auditors\",\"Investors\",\"Venture Capital\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/\",\"url\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/\",\"name\":\"Vogel Heerma Waitz advises Captain T Cell on seed financing round - FYB Financial Yearbook\",\"isPartOf\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/05\/olav-wilms1024x1024-768113175.jpg\",\"datePublished\":\"2024-05-26T08:07:37+00:00\",\"dateModified\":\"2024-05-28T16:07:37+00:00\",\"description\":\"Berlin, Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, successfully closes a seed financing round of 8.5 million euros.\",\"breadcrumb\":{\"@id\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#primaryimage\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/05\/olav-wilms1024x1024-768113175.jpg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/05\/olav-wilms1024x1024-768113175.jpg\",\"width\":1024,\"height\":1024,\"caption\":\"Olav Wilms, bei Co-Gesch\u00e4ftsf\u00fchrer bnei Brandenburg Capital\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/www.fyb.de\/en\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Vogel Heerma Waitz advises Captain T Cell on seed financing round\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/www.fyb.de\/en\/#website\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"name\":\"FYB Financial Yearbook\",\"description\":\"For Your Business\",\"publisher\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/www.fyb.de\/en\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/www.fyb.de\/en\/#organization\",\"name\":\"FYB Financial Yearbook\",\"url\":\"https:\/\/www.fyb.de\/en\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"contentUrl\":\"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg\",\"caption\":\"FYB Financial Yearbook\"},\"image\":{\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce\",\"name\":\"Tatjana Anderer\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g\",\"caption\":\"Tatjana Anderer\"},\"description\":\"Gr\u00fcnderin des FYB-Verlag\",\"sameAs\":[\"http:\/\/neu.fyb.de\"],\"url\":\"https:\/\/www.fyb.de\/en\/author\/tanderer\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Vogel Heerma Waitz advises Captain T Cell on seed financing round - FYB Financial Yearbook","description":"Berlin, Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, successfully closes a seed financing round of 8.5 million euros.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/","og_locale":"en_US","og_type":"article","og_title":"Vogel Heerma Waitz advises Captain T Cell on seed financing round - FYB Financial Yearbook","og_description":"Berlin, Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, successfully closes a seed financing round of 8.5 million euros.","og_url":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/","og_site_name":"FYB Financial Yearbook","article_published_time":"2024-05-26T08:07:37+00:00","article_modified_time":"2024-05-28T16:07:37+00:00","og_image":[{"width":1024,"height":1024,"url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/05\/olav-wilms1024x1024-768113175.jpg","type":"image\/jpeg"}],"author":"Tatjana Anderer","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Tatjana Anderer","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#article","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/"},"author":{"name":"Tatjana Anderer","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce"},"headline":"Vogel Heerma Waitz advises Captain T Cell on seed financing round","datePublished":"2024-05-26T08:07:37+00:00","dateModified":"2024-05-28T16:07:37+00:00","mainEntityOfPage":{"@id":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/"},"wordCount":396,"publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"image":{"@id":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/05\/olav-wilms1024x1024-768113175.jpg","articleSection":["General","Featured","News","Lawyers\/Tax-advisors\/Auditors","Investors","Venture Capital"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/","url":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/","name":"Vogel Heerma Waitz advises Captain T Cell on seed financing round - FYB Financial Yearbook","isPartOf":{"@id":"https:\/\/www.fyb.de\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#primaryimage"},"image":{"@id":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#primaryimage"},"thumbnailUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/05\/olav-wilms1024x1024-768113175.jpg","datePublished":"2024-05-26T08:07:37+00:00","dateModified":"2024-05-28T16:07:37+00:00","description":"Berlin, Captain T Cell GmbH, a biotechnology company developing next-generation T cells against solid tumors, successfully closes a seed financing round of 8.5 million euros.","breadcrumb":{"@id":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#primaryimage","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/05\/olav-wilms1024x1024-768113175.jpg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2024\/05\/olav-wilms1024x1024-768113175.jpg","width":1024,"height":1024,"caption":"Olav Wilms, bei Co-Gesch\u00e4ftsf\u00fchrer bnei Brandenburg Capital"},{"@type":"BreadcrumbList","@id":"https:\/\/www.fyb.de\/en\/vogel-heerma-waitz-advises-captain-t-cell-on-seed-financing-round\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.fyb.de\/en\/"},{"@type":"ListItem","position":2,"name":"Vogel Heerma Waitz advises Captain T Cell on seed financing round"}]},{"@type":"WebSite","@id":"https:\/\/www.fyb.de\/en\/#website","url":"https:\/\/www.fyb.de\/en\/","name":"FYB Financial Yearbook","description":"For Your Business","publisher":{"@id":"https:\/\/www.fyb.de\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.fyb.de\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/www.fyb.de\/en\/#organization","name":"FYB Financial Yearbook","url":"https:\/\/www.fyb.de\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/","url":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","contentUrl":"https:\/\/www.fyb.de\/wp-content\/uploads\/2020\/06\/logo.svg","caption":"FYB Financial Yearbook"},"image":{"@id":"https:\/\/www.fyb.de\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/4308b3086925bc8567ceba3ebd69b4ce","name":"Tatjana Anderer","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.fyb.de\/en\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/11708a5289b743e6290bae8e4109e97efec1cb1ae5c7065f0bfc5c36f28c7757?s=96&d=mm&r=g","caption":"Tatjana Anderer"},"description":"Gr\u00fcnderin des FYB-Verlag","sameAs":["http:\/\/neu.fyb.de"],"url":"https:\/\/www.fyb.de\/en\/author\/tanderer\/"}]}},"_links":{"self":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/51505","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/comments?post=51505"}],"version-history":[{"count":0,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/posts\/51505\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media\/51502"}],"wp:attachment":[{"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/media?parent=51505"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/categories?post=51505"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.fyb.de\/en\/wp-json\/wp\/v2\/tags?post=51505"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}